🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

85 results for “Rhythm” Clear

  1. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypertriglyceridemia

    phase 2 small molecule completed

    1 trial

  2. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Prader-Willi Syndrome

    phase 2 small molecule active

    2 trials

  3. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Genetic Obesity

    phase 2 small molecule completed

    2 trials

  4. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Overweight and Obesity

    phase 2 small molecule completed

    1 trial

  5. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Overweight

    phase 2 small molecule completed

    1 trial

  6. Single Site Pacing

    Rhythm Pharmaceuticals Netherlands B.V.

    Acute Myocardial Infarction

    phase 2 other completed

    1 trial

  7. Tideglusib

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmogenic Cardiomyopathy

    phase 2 small molecule active

    1 trial

  8. VEC-162

    Vanda Pharmaceuticals Netherlands B.V.

    Circadian Rhythm Sleep Disorders

    phase 2 small molecule completed

    1 trial

  9. A SINGLE-CENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF REPEAT DOSES OF ARM210 IN HEALTHY SUBJECTS.

    Pharma Mar S.A.

    Cardiac arrhythmias

    phase 1 other active

    1 trial

  10. A first-in-human study to learn about how safe the study drug is in healthy participants

    Bayer AG

    Cardiac arrhythmia

    phase 1 other active

    1 trial

  11. Ablation procedure and/or cardioversion

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    phase 1 other completed

    1 trial

  12. Baroreceptor Stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypertension

    phase 1 other completed

    1 trial

  13. Bupivacaine alone OR Bupivacaine-Ketorolac-Ketamine (BKK) Combination

    Rhythm Pharmaceuticals Netherlands B.V.

    Pain Management

    phase 1 small molecule active

    1 trial

  14. Cardiac Resynchronization Therapy

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 1 other completed

    1 trial

  15. MARVEL algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrioventricular Conduction Block

    phase 1 other completed

    1 trial

  16. Pacing Lead

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 1 other completed

    1 trial

  17. Placebo

    Rhythm Pharmaceuticals Netherlands B.V.

    Obesity

    phase 1 small molecule completed

    1 trial

  18. RM-493

    Rhythm Pharmaceuticals Netherlands B.V.

    Overweight

    phase 1 small molecule completed

    1 trial

  19. RP-A601

    Rocket Pharmaceuticals B.V.

    PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

    phase 1 gene therapy active

    1 trial

  20. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Renal Insufficiency

    phase 1 small molecule completed

    1 trial

  21. TN-401

    Tenaya Therapeutics

    Arrhythmogenic Right Ventricular Cardiomyopathy

    phase 1 gene therapy active

    1 trial

  22. Vagal Nerve Stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Inflammation

    phase 1 other completed

    1 trial

  23. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Circadian Rhythm Sleep Disorders

    phase 1 small molecule completed

    1 trial

  24. Ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources